Corpus Intelligence IC Memo — CHI ST. VINCENT HOT SPRINGS REHABILI 2026-04-26 06:55 UTC
IC Memo — CHI ST. VINCENT HOT SPRINGS REHABILI
Investment Committee Memorandum | AR | 48 beds | Grade D | EBITDA uplift $1.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

CHI ST. VINCENT HOT SPRINGS REHABILI

CCN 043035 | GARLAND, AR | 48 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

CHI ST. VINCENT HOT SPRINGS REHABILI is a 48-bed suburban community hospital in GARLAND, AR with $25.0M in net patient revenue and a 27.4% operating margin. The hospital serves a payer mix of 73.9% Medicare, 5.5% Medicaid, and 20.7% commercial.

Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 27.4% to 34.7% (+736bps).

Net Revenue HCRIS$25.0M
Current EBITDA COMPUTED$6.8M
Operating Margin COMPUTED27.4%
Occupancy HCRIS87.9%
Revenue / Bed COMPUTED$520K
Net-to-Gross HCRIS67.7%
Distress Probability ML46.7%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
62
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of 27.4% places it above the state median. Among 62 size-comparable peers (24-96 beds), the median margin is -12.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (24-96), prioritizing same-state peers. 62 hospitals in the comp set.

HospitalStateBedsRevenueMargin
CHI ST. VINCENT HOT SPRINGS RE (Target)AR48$25.0M27.4%
ARKANSAS CHILDRENS NORTHWESTAR24$113.6M7.2%
SILOAM SPRINGS MEMORIAL HOSPITAR64$85.0M8.4%
ARKANSAS SURGICAL HOSPITALAR47$75.1M11.7%
ST VINCENT NORTHAR68$72.1M-18.7%
ENCORE MEDICAL CENTERAR25$55.7M-4.7%
OZARKS COMMUNITY HOSPITAL OF GAR25$48.6M-21.0%
ENCOMPASS HEALTH REHABILITATIOAR80$36.3M27.9%
DREW MEMORIAL HOSPITAL INCAR49$35.3M-27.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$524K+210bp18mo
Cost to Collect4.5%2.5%$499K+200bp12mo
Denial Rate Reduction12.0%6.5%$494K+198bp12mo
A/R Days Reduction5200.0%3800.0%$304K+122bp9mo
Clean Claim Rate88.0%96.0%$16K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$524K
Cost to Collect
$499K
Denial Rate Reduction
$494K
A/R Days Reduction
$304K
Clean Claim Rate
$16K
Total EBITDA Uplift$1.8M
Current EBITDA$6.8M
+ RCM Uplift+$1.8M
Pro Forma EBITDA$8.7M
Current Margin27.4%
Pro Forma Margin34.7%
WC Released (1x)$957K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$10.5M$63.4M6.04x43.3%
Base (11x exit)10.0x11.0x$10.5M$73.2M6.96x47.4%
Bull Case9.0x11.0x$9.5M$82.7M8.74x54.3%
Bull (12x exit)9.0x12.0x$9.5M$93.0M9.83x58.0%
Bear Case11.0x10.0x$11.6M$50.8M4.40x34.5%
Bear (11x exit)11.0x11.0x$11.6M$59.7M5.16x38.9%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 73.9% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 62 hospitals with 24-96 beds
  • Same-state prioritization (n=63)
  • Comp margins: P25=-24.2% / P50=-12.4% / P75=5.4%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.